Mikkel Bring Christensen
Clinical Professor
- 2018
- Published
Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes
Nerild, H. H., Christensen, Mikkel Bring, Knop, Filip Krag & Brønden, A., 2018, In: Expert Opinion on Drug Discovery. 13, 12, p. 1161-1167 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Response to Letter to the Editor: "Hemodynamic Effects of Glucagon: A Literature Review"
Petersen, K. M., Bøgevig, S., Holst, Jens Juul, Knop, Filip Krag & Christensen, Mikkel Bring, 2018, In: The Journal of clinical endocrinology and metabolism. 103, 12, p. 4480-4481 2 p.Research output: Contribution to journal › Comment/debate › Research
- Published
The role of the incretins in the postprandial bone remodelling
Helsted, M. M., Gasbjerg, Lærke Smidt, Lanng, A. R., Stensen, S., Hartmann, Bolette, Christensen, Mikkel Bring, Holst, Jens Juul, Vilsbøll, Tina, Rosenkilde, M. M. & Knop, Filip Krag, 2018, In: Diabetologia. 61, S1, p. S221-S221 449.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Ventrikelaspiration er meget sjældent indiceret ved forgiftninger
Bøgevig, S., Christensen, Mikkel Bring, Petersen, J. A., Dalhoff, Kim, Petersen, Tonny Studsgaard, Palmqvist, D. F. & Groth Høgberg, L. C., 2018, In: Ugeskrift for Laeger. 180, 49, 4 p., V04180252.Research output: Contribution to journal › Journal article › Research › peer-review
- 2017
- Published
An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions
Vinther, S., Klarskov, P., Borgeskov, H., Darso, P., Christophersen, A. K., Borck, B., Christensen, C., Hansen, M. V., Halladin, N. M. L., Christensen, Mikkel Bring, Harboe, K. M., Lund, M. & Solem, Espen Victor Jimenez, 2017, In: Danish Medical Journal. 64, 1, 5 p., A5315.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide
Brønden, A., Knop, Filip Krag & Christensen, Mikkel Bring, 2017, In: Clinical Pharmacokinetics. 56, 7, p. 719-731Research output: Contribution to journal › Review › Research › peer-review
- Published
Quality of care for people with multimorbidity: a case series
Schiøtz, M. L., Høst, D., Christensen, Mikkel Bring, Domínguez, H., Hamid, Y., Almind, M., Sørensen, K. L., Saxild, T., Holm, R. H. & Frølich, A., 2017, In: BMC Health Services Research. 17, 9 p., 745.Research output: Contribution to journal › Journal article › Research › peer-review
- 2016
- Published
Higher Endogenous Glucose Production during OGTT vs Isoglycemic Intravenous Glucose Infusion
Lund, Asger Bach, Bagger, J. I., Christensen, Mikkel Bring, Grøndahl, M., van Hall, Gerrit, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, Nov 2016, In: The Journal of Clinical Endocrinology & Metabolism. 101, 11, p. 4377-4384Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans
Christensen, Mikkel Bring, Apr 2016, In: Danish Medical Journal. 63, 4, p. 1-19 19 p., B5230.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Storgaard, H., Gluud, Lise Lotte, Bennett, C., Grøndahl, M. F., Christensen, Mikkel Bring, Knop, Filip Krag & Vilsbøll, Tina, 2016, In: PLOS ONE. 11, 11, 23 p., e0166125.Research output: Contribution to journal › Review › Research › peer-review
- 2015
- Published
Laktoseholdige lægemidler kan som hovedregel indtages af personer med laktoseintolerans
Vinther, S., Rumessen, J. J. & Christensen, Mikkel Bring, 9 Mar 2015, In: Ugeskrift for Laeger. 177, 24, p. 2-5 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes
Christensen, Mikkel Bring, Calanna, S., wbf943, wbf943, Kristensen, P. L., Rosenkilde, Mette, Faber, Jens, Purrello, F., van Hall, Gerrit, Holst, Jens Juul, Vilsbøll, T. & Knop, Filip Krag, Jan 2015, In: Diabetes. 64, 1, p. 72-78 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2014
- Published
Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans
Nissen, A., Christensen, Mikkel Bring, Knop, Filip Krag, Vilsbøll, T., Holst, Jens Juul & Hartmann, Bolette, Nov 2014, In: The Journal of clinical endocrinology and metabolism. 99, 11, p. E2325-9 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease
Idorn, T., Knop, Filip Krag, Jørgensen, M. B., Christensen, Mikkel Bring, Holst, Jens Juul, Hornum, Mads & Feldt-Rasmussen, Bo, 8 Apr 2014, In: The Journal of clinical endocrinology and metabolism. 99, 7, p. 2457-66 10 p., jc20133809.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes
Christensen, Mikkel Bring, Calanna, S., Holst, Jens Juul, Vilsbøll, T. & Knop, Filip Krag, Mar 2014, In: The Journal of clinical endocrinology and metabolism. 99, 3, p. E418-26 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials
Storgaard, H., Gluud, Lise Lotte, Christensen, Mikkel Bring, Knop, Filip Krag & Vilsbøll, T., 2014, In: B M J Open. 4, 8, p. 1-5 5 p., e005378.Research output: Contribution to journal › Journal article › Research › peer-review
- 2013
- Published
Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies
Calanna, S., Christensen, Mikkel Bring, Holst, Jens Juul, Laferrère, B., Gluud, Lise Lotte, Vilsbøll, T. & Knop, Filip Krag, Oct 2013, In: Diabetes Care. 36, 10, p. 3346-52 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations
Jespersen, M. J., Knop, Filip Krag & Christensen, Mikkel Bring, 2013, In: Expert Opinion on Drug Metabolism & Toxicology. 9, 1, p. 17-29 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 96275756
Most downloads
-
218
downloads
Quality of care for people with multimorbidity: a case series
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
185
downloads
Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
142
downloads
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease
Research output: Contribution to journal › Journal article › Research › peer-review
Published